In contrast, miR-132 is highly overexpressed in tumor endothelium [40], where it stimulates VEGF driven Ras-Raf-Mek-Erk signaling through targeting RAS p21 protein activator (RASA1; p120 RasGAP), a negative regulator of Ras [40]. Here, VEGFA is linked to neoplasm.